Genocea Biosciences (NASDAQ: GNCA) reported Q2 EPS of ($0.28), $0.18 better than the analyst estimate of ($0.46).“The data ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE